No, Do Not Order FOBT for Melena
If a patient presents with melena, you should NOT order a fecal occult blood test (FOBT). Melena is already overt evidence of gastrointestinal bleeding, making FOBT unnecessary and potentially misleading.
Why FOBT is Inappropriate in Melena
The Test is Designed for Screening, Not Diagnosis
FOBT is FDA-approved exclusively for colorectal cancer screening in asymptomatic outpatients 1, 2. When a patient has melena—black, tarry stools indicating upper GI bleeding—the presence of blood is already clinically evident. Ordering FOBT in this context is considered low-value and unnecessary 3.
Clinical Problems with FOBT in Overt Bleeding
- False negatives occur: FOBT can miss active bleeding, potentially delaying appropriate intervention 4, 2
- False positives are common: Leading to unnecessary procedures and increased costs 1, 2
- Poor predictive accuracy: ED clinicians can only predict FOBT results with 75% accuracy, and even when they're "certain" of a positive result, they're wrong 21% of the time 4
- Doesn't change management: Studies show FOBT results rarely alter clinical decision-making in patients with suspected GI bleeding 3, 2, 5
What You Should Do Instead
For patients with melena, proceed directly to:
- Hemodynamic assessment and resuscitation if needed
- Laboratory evaluation: Complete blood count to assess hemoglobin/hematocrit and degree of anemia
- Upper endoscopy (EGD): This is the first-line diagnostic and therapeutic investigation for overt upper GI bleeding 6, 7
The AGA guidelines specifically address melena as overt bleeding requiring repeat endoscopic examinations when appropriate, not stool testing 6.
Common Pitfall to Avoid
The most frequent misuse of FOBT occurs when clinicians order it for patients with visible signs of bleeding (melena, hematochezia, hematemesis) 3, 2. Recent quality improvement initiatives have successfully removed FOBT from emergency department and inpatient order sets precisely because of this inappropriate use 3.
In a patient with melena, the blood is already visible (albeit digested). Testing to confirm occult blood makes no clinical sense and delays appropriate endoscopic evaluation.